N4 Pharma Plc (LON:N4P – Get Free Report) passed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of GBX 0.53 ($0.01) and traded as low as GBX 0.50 ($0.01). N4 Pharma shares last traded at GBX 0.58 ($0.01), with a volume of 3,777,685 shares changing hands.
N4 Pharma Price Performance
The company has a market cap of £2.31 million, a price-to-earnings ratio of -57.50 and a beta of -0.37. The company has a current ratio of 14.86, a quick ratio of 7.28 and a debt-to-equity ratio of 1.62. The business has a 50-day moving average price of GBX 0.53 and a 200 day moving average price of GBX 0.62.
About N4 Pharma
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Read More
- Five stocks we like better than N4 Pharma
- EV Stocks and How to Profit from Them
- How Much Can You Make in Stocks in One Month?
- Stock Market Upgrades: What Are They?
- This Is the Top Large-Cap Stock Insiders Are Buying
- How to invest in marijuana stocks in 7 steps
- Capitalize on Micron’s 24% Drop—Wall Street Eyes Major Upside
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
